Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-alpha in mice with acute graft-versus-host disease

被引:35
|
作者
Falzarano, G
Krenger, W
Snyder, KM
Delmonte, J
Karandikar, M
Ferrara, JLM
机构
[1] DANA FARBER CANC INST, DIV PEDIAT ONCOL, BOSTON, MA 02115 USA
[2] CHILDRENS HOSP, BOSTON, MA USA
[3] HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA
关键词
D O I
10.1182/blood.V87.7.2853.bloodjournal8772853
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graft-versus-host disease (GVHD) is associated with impaired B-cell responses. We investigated the mechanism of impaired proliferation of B cells in response to the mitogen lipopolysaccharide (LPS) by analyzing the production of tumor necrosis factor-alpha (TNF-alpha) and nitric oxide (NO), both of which have independently been described as important effector mechanisms in the pathogenesis of acute GVHD. A threefold decrease of mature surface Ig-positive (sIg(+)) B cells was observed in GVHD spleens isolated 2 weeks after transplant. However, proliferation of these cells in response to LPS was suppressed by more than 35-fold. Activated GVHD splenocytes secreted large amounts of TNF-alpha and NO in culture, Neutralization of TNF-alpha with anti-TNF-alpha antibody (Ab) both abrogated NO production and restored LPS-induced proliferation of B cells to levels found in non-GVHD control mice. The specific inhibition of NO synthesis with L(G)-monomethyl-arginine (NNMA) restored splenocyte responses but did not significantly reduce TNF-alpha levels, showing that TNF-alpha per se did not cause immunosuppression. These data show that, during GVHD, induction of the MO pathway is an important mechanism that mediates B-cell hyporesponsiveness to LPS and that this pathway is induced by TNF-alpha. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:2853 / 2860
页数:8
相关论文
共 50 条
  • [1] SERUM TUMOR NECROSIS FACTOR-ALPHA ASSOCIATED WITH ACUTE GRAFT-VERSUS-HOST DISEASE IN HUMANS
    SYMINGTON, FW
    PEPE, MS
    CHEN, AB
    DELIGANIS, A
    TRANSPLANTATION, 1990, 50 (03) : 518 - 521
  • [2] PREVENTION OF THE GRAFT-VERSUS-HOST REACTION IN NEWBORN MICE BY ANTIBODIES TO TUMOR NECROSIS FACTOR-ALPHA
    SHALABY, MR
    FENDLY, B
    SHEEHAN, KC
    SCHREIBER, RD
    AMMANN, AJ
    TRANSPLANTATION, 1989, 47 (06) : 1057 - 1061
  • [3] Effect of ursodeoxycholic acid on expression of Fas ligand and tumor necrosis factor-alpha in the liver of mice with acute graft-versus-host disease
    Kuroiwa, T
    Iwasaki, T
    Kataoka, Y
    Iwata, N
    Seto, Y
    Hamano, T
    Terada, N
    Kakishita, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (11): : 825 - 836
  • [4] MACROPHAGE PRIMING AND LIPOPOLYSACCHARIDE-TRIGGERED RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA DURING GRAFT-VERSUS-HOST DISEASE
    NESTEL, FP
    PRICE, KS
    SEEMAYER, TA
    LAPP, WS
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02): : 405 - 413
  • [5] Sodium butyrate suppresses interferon-gamma-, but not lipopolysaccharide-mediated induction of nitric oxide and tumor necrosis factor-alpha in microglia
    Kim, HS
    Whang, SY
    Woo, MS
    Park, JS
    Kim, WK
    Han, IO
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 151 (1-2) : 85 - 93
  • [6] Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice
    Vallera, DA
    Taylor, PA
    Vannice, JL
    PanoskaltsisMortari, A
    Blazar, BR
    TRANSPLANTATION, 1995, 60 (11) : 1371 - 1374
  • [7] Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease
    Cooke, KR
    Hill, GR
    Crawford, JM
    Bungard, D
    Brinson, YS
    Delmonte, J
    Ferrara, JLM
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (10): : 1882 - 1891
  • [8] Toxic epidermal necrolysis in the setting of acute graft-versus-host disease successfully treated with tumor necrosis factor alpha inhibitors
    Seminario-Vidal, L.
    Vera, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S48 - S48
  • [9] Validation of B cell activating factor as a biomarker for acute graft-versus-host disease
    Surtee, S. A.
    Atarod, S.
    Ahmed, S.
    Dickinson, A. M.
    SCOTTISH MEDICAL JOURNAL, 2014, 59 (01) : E30 - E30
  • [10] TUMOR-NECROSIS-FACTOR-ALPHA AND GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANT RECIPIENTS
    SHERMAN, JM
    FRIEDMAN, DJ
    BOWMAN, WP
    SANDERS, JM
    GRIFFIN, TG
    BLOOD, 1994, 84 (10) : A731 - A731